Conference Call Alert - Neurobiological Technologies, Inc. (Nasdaq: NTII)
November 05 2003 - 9:30AM
PR Newswire (US)
Conference Call Alert - Neurobiological Technologies, Inc. (Nasdaq:
NTII) RICHMOND, Calif., Nov. 5 /PRNewswire-FirstCall/ -- NTI(R) has
arranged a conference call to discuss the financial results for the
first quarter ended September 30, 2003. Paul Freiman, President and
Chief Executive Officer, will host the call. Live Call: Date:
Wednesday, November 12, 2003 Time: 10:30 a.m. ET, 9:30 a.m. CT,
7:30 a.m. PT Dial-in number: 800-289-0529 Web Cast of Call: A live
web cast can be accessed by going to:
http://www.shareholder.com/ntii/medialist.cfm Call Replay: A
playback of the conference call will be available on November 12 at
1:30 p.m. ET through midnight on November 20th ET Replay number:
(888) 203-1112 (U.S. and Canada) & (719) 457-0820 (Int'l)
Replay access code: 376262 About the Company: NTI is an emerging
drug development company focused on the clinical evaluation and
regulatory approval of neuroscience drugs. The Company's strategy
is to in-license and develop early- and later-stage drug candidates
that target major medical needs and which can be rapidly
commercialized. The Company's experienced management team oversees
the human clinical trials necessary to establish preliminary
evidence of efficacy and seeks partnerships with pharmaceutical and
biotechnology companies to complete development and marketing of
its product candidates. DATASOURCE: Neurobiological Technologies,
Inc. CONTACT: Paul Freiman, President and CEO of Neurobiological
Technologies, Inc., +1-510-262-1730, Web site: http://www.ntii.com/
Copyright